- Home
- MPB vs ANGO Comparison
MPB vs ANGO Comparison
Compare MPB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- ANGO
- Stock Information
- Founded
- MPB 1868
- ANGO 1988
- Country
- MPB United States
- ANGO United States
- Employees
- MPB N/A
- ANGO N/A
- Industry
- MPB Major Banks
- ANGO Medical/Dental Instruments
- Sector
- MPB Finance
- ANGO Health Care
- Exchange
- MPB Nasdaq
- ANGO Nasdaq
- Market Cap
- MPB 467.7M
- ANGO 439.5M
- IPO Year
- MPB N/A
- ANGO 2004
- Fundamental
- Price
- MPB $28.20
- ANGO $9.11
- Analyst Decision
- MPB Buy
- ANGO Strong Buy
- Analyst Count
- MPB 2
- ANGO 2
- Target Price
- MPB $36.00
- ANGO $14.00
- AVG Volume (30 Days)
- MPB 137.0K
- ANGO 330.9K
- Earning Date
- MPB 04-23-2025
- ANGO 04-02-2025
- Dividend Yield
- MPB 2.84%
- ANGO N/A
- EPS Growth
- MPB 23.94
- ANGO N/A
- EPS
- MPB 2.88
- ANGO N/A
- Revenue
- MPB $181,865,000.00
- ANGO $283,320,000.00
- Revenue This Year
- MPB $19.07
- ANGO N/A
- Revenue Next Year
- MPB $11.53
- ANGO $6.35
- P/E Ratio
- MPB $9.80
- ANGO N/A
- Revenue Growth
- MPB 8.94
- ANGO N/A
- 52 Week Low
- MPB $19.75
- ANGO $5.47
- 52 Week High
- MPB $33.87
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- MPB 56.40
- ANGO 46.41
- Support Level
- MPB $26.16
- ANGO $8.55
- Resistance Level
- MPB $29.57
- ANGO $9.68
- Average True Range (ATR)
- MPB 1.16
- ANGO 0.36
- MACD
- MPB 0.09
- ANGO -0.02
- Stochastic Oscillator
- MPB 63.93
- ANGO 46.28
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.